ArticleInternational journal of cancer2012

Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.

Kevin R Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.